A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients

Clinical trial NCT00451412 · COMPLETED

Trial details

NCT number: NCT00451412
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism

Start date: 2007-01-01
Primary completion: 2009-06-01
Enrollment: 3254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.